CIK 0002042347
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Seaport Therapeutics, Inc.
Sign in to watch- Ticker
- SPTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 992235719
- Phone
- +1 617-807-4062
- Business address
- 6 TIDE STREET, SUITE 400, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $99,325
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,325. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Zohar Daphne Chief Executive Officer | Gift | −100,000 | 1,094,001 | ||
| 2026-04-30 | Zohar Daphne Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +271,813 | 271,813 | ||
| 2026-04-30 | Zohar Daphne Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,486,786 | 1,486,786 |
Page 1 of 1 · 3 trades